Wellington Management Group LLP Astrazeneca PLC Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 35,630,680 shares of AZN stock, worth $2.64 Billion. This represents 0.52% of its overall portfolio holdings.

Number of Shares

35,630,680

Holding current value

$2.64 Billion

% of portfolio

0.52%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$65.37 - $77.96 $2.33 Billion - $2.78 Billion	35,630,680 New	35,630,680 $2.62 Billion
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $13.2 Million - $16.6 Million	-208,198 Reduced 0.56%	37,038,885 $2.43 Billion
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $255 Million - $291 Million	-3,322,834 Reduced 8.19%	37,247,083 $2.9 Billion
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $571 Million - $691 Million	-8,551,944 Reduced 17.41%	40,569,917 $3.16 Billion
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $3 Billion - $3.42 Billion	49,121,861 New	49,121,861 $3.33 Billion
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $3.06 Billion - $3.43 Billion	49,444,180 New	49,444,180 $3.33 Billion
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $23.2 Million - $25.7 Million	358,399 Added 0.73%	49,492,814 $3.35 Billion
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $246 Million - $267 Million	-3,520,087 Reduced 6.69%	49,134,415 $3.52 Billion
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $123 Million - $140 Million	-1,951,550 Reduced 3.57%	52,654,502 $3.65 Billion
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $128 Million - $166 Million	2,359,136 Added 4.52%	54,606,052 $3.7 Billion
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $209 Million - $536 Million	3,948,994 Added 8.18%	52,246,916 $2.87 Billion
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $95.2 Million - $114 Million	1,606,887 Added 3.44%	48,297,922 $3.19 Billion
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $23.1 Million - $27.8 Million	-414,016 Reduced 0.88%	46,691,035 $3.1 Billion
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $326 Million - $386 Million	-6,040,513 Reduced 11.37%	47,105,051 $2.74 Billion
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $251 Million - $275 Million	4,526,346 Added 9.31%	53,145,564 $3.19 Billion
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $31.1 Million - $38.6 Million	-642,215 Reduced 1.3%	48,619,218 $2.91 Billion
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $31.8 Million - $36.7 Million	673,447 Added 1.39%	49,261,433 $2.45 Billion
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $170 Million - $203 Million	-3,505,697 Reduced 6.73%	48,587,986 $2.43 Billion
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $130 Million - $150 Million	-2,450,834 Reduced 4.49%	52,093,683 $2.85 Billion
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $552 Million - $709 Million	-12,813,874 Reduced 19.02%	54,544,517 $2.88 Billion
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $81.8 Million - $111 Million	2,163,500 Added 3.32%	67,358,391 $3.01 Billion
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $2.77 Billion - $3.29 Billion	65,194,891 New	65,194,891 $3.25 Billion

Others Institutions Holding AZN

# of Institutions

1,422

Shares Held

509M

Call Options Held

9.82M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Astrazeneca PLC Transaction History